Skin has limited capacity to respond to signaling molecules
Endoscopy 42 , 790799 (2010)
Some studies note potential additional effects like lower risks for certain conditions, though long-term data continues to evolve
The mean levels of monitoring variables before and after intervention are shown in Table 4
Retrieved 26 February 2021, from Albumin_Bioconjugates_Activate_the_GRF_Receptor_on_the_Anterior_Pituitary_in_ Rats_Identification_of_CJC-1295_as_a_Long_Lasting_GRF_Analog
In 2003, there seemed to be good reasons to leave weight-loss drugs out of the benefit, write Inmaculada Hernandez of the University of California, San Diego, and coauthors in their September 2023 editorial in the Journal of General Internal Medicine, Medicare Part D Coverage of Anti-obesity Medications: a Call for Forward-Looking Policy Reform. When members of Congress worked on the Part D benefit, the drugs available on the market were known to have limited effectiveness and unpleasant side effects